-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-09-01
The reference study identifies an O-GlcNAc–HUWE1–TfR1 regulatory axis that connects trophoblast ferroptosis, iron handling, and syncytialization defects in preeclampsia. By combining placental analyses, O-GlcNAc proteomics, trophoblast models, and mouse experiments, the work provides a mechanistic framework for testing O-GlcNAc-centered interventions in placental disease.
-
TMRE and the Bioenergetics of Sodium-Driven Cell Death
2026-09-01
A mechanistic and translational guide to using TMRE fluorescence to connect sodium-driven mitochondrial energy failure with apoptosis research, mitochondrial function analysis, and experimentally defensible assay design.
-
Rational n-Alkyl Design of Copper Ionophores
2026-08-31
The reference study shows that simple n-alkyl chain modification can substantially tune copper-ionophore performance, with C6 providing the best balance of copper binding, lipophilicity, and intracellular transport. C6 induced cuproptosis-associated mitochondrial damage in triple-negative breast cancer models while retaining low systemic toxicity and producing antitumor and immunomodulatory effects.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-31
Build a two-channel assay that separates mRNA delivery from protein expression in mammalian cells. This workflow uses Cy5 to track intracellular cargo and EGFP to quantify translation, making it practical for comparing transfection reagents, lipid nanoparticles, and emerging delivery systems.
-
ZNF263, ULK1, and Autophagy in ICC
2026-08-30
This reference study identifies ZNF263 as an enhancer-associated transcriptional regulator that promotes intrahepatic cholangiocarcinoma proliferation through the ULK1–autophagy axis. By combining tissue analysis, genetic perturbation, CUT&Tag, RNA sequencing, chromatin validation, reporter assays, and xenograft experiments, it connects ZNF263-mediated gene expression regulation with a functional cancer phenotype.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-29
Build sensitive, reproducible reporter assays with Cap1- and poly(A)-optimized EZ Cap™ Firefly Luciferase mRNA. This practical guide covers delivery, translation readouts, in vivo imaging, upstream RNA-quality considerations, and troubleshooting from sample preparation through data normalization.
-
Entecavir Workflows for HBV Replication Studies
2026-08-28
Build reproducible HBV replication assays around Entecavir, from DMSO stock preparation and nanomolar dose-response testing to resistant-strain comparisons and translational interpretation. The workflow separates compound handling, assay controls, and clinical context so researchers can distinguish genuine polymerase inhibition from model or dosing artifacts.
-
Caspase-8 Fluorometric Assay Kit in Therapy Studies
2026-08-28
The Caspase-8 Fluorometric Assay Kit provides a functional readout of IETD-dependent protease activity for therapy-response studies. This article explains how to use caspase-8 activity measurement to distinguish enzyme activation, protein accumulation, apoptosis, and pyroptosis.
-
Vorinostat and mRNA Lipoplex Protein Expression
2026-08-27
This 2024 study examined whether the HDAC inhibitor vorinostat could increase protein production after mRNA lipoplex delivery. Low-dose vorinostat enhanced luciferase expression in HeLa and HepG2 cells, but its effects in mice were modest and differed between tissue distribution and functional protein output.
-
Firefly Luciferase mRNA: Delivery & Assay Workflow
2026-08-27
Build a sensitive mRNA delivery and translation efficiency assay around Cap1-capped, 5-moUTP-modified Firefly Luciferase mRNA. This workflow separates delivery, transcript stability, translation, and cell-health effects while extending from routine plate assays to formulation screening and in vivo imaging.
-
ddATP and DNA Damage: Reading Replication in Oocytes
2026-08-26
ddATP is more than a sequencing reagent: its chain-termination chemistry can help test whether DNA synthesis amplifies damage signals. This article translates oocyte break-induced replication findings into a rigorous assay-design framework while defining the limits of cross-application.
-
Pickering Multiple Emulsions for Cancer mRNA Vaccines
2026-08-26
Yufei Xia’s 2024 Gunma University dissertation develops water-in-oil-in-water Pickering multiple emulsions as a combined protection, delivery, and immune-activation platform for protein and mRNA cancer vaccines. Calcium phosphate-stabilized emulsions produced the most consistent dendritic-cell activation, local mRNA expression, immune-cell recruitment, and tumor-suppressive effects in the reported mouse studies.
-
GKT137831: Nox1/Nox4 Inhibitor Workflow
2026-08-25
GKT137831 gives researchers a controlled way to test how Nox1/Nox4-derived oxidative stress shapes pulmonary vascular, fibrotic, metabolic, and cardiac phenotypes. This workflow also connects upstream ROS control with newer ferroptosis assays focused on plasma-membrane damage, lipid scrambling, and immune-relevant danger signaling.
-
AI-10-49 Reframes inv(16) AML Research
2026-08-25
AI-10-49 provides a mechanism-led way to interrogate the CBFβ-SMMHC/RUNX1 axis in inv(16) acute myeloid leukemia research. By connecting fusion-protein disruption with restored RUNX1 occupancy and the N-MYC/eIF4G1 survival program, this article outlines practical validation workflows and translational decision points beyond a conventional product overview.
-
Cyanin Chloride in a HaCaT Psoriasis Model
2026-08-24
A 2024 study tested cyanin chloride in chemical radical assays, LPS-stimulated macrophages, and a cytokine-induced HaCaT keratinocyte model of psoriasis. Its central contribution was to connect reduced inflammatory signaling, including STAT3 phosphorylation and CCL20 expression, with recovery of epithelial barrier function measured by TEER, while also highlighting the need to distinguish cyanin chloride from the separately defined compound Cyanidin Chloride.